Easy-to-swallow Zantac
This article was originally published in The Tan Sheet
Executive Summary
Glaxo's NDA for 150 and 300 mg doses of the prescription anti- ulcer drug Zantac in GELdose capsules is deemed "approvable" by FDA on April 30. Glaxo said that the GELdose capsules are "easier for some people to swallow." Zantac has been touted as a possible Rx-to-OTC switch candidate; however, the Glaxo product lags behind other H[2] antagonist switches at FDA.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning